Veltio Pharma Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$343K
- Investors
-
2
Veltio Pharma General Information
Description
Developer of proprietary nanotechnology platform designed to improve the solid oral dosage of medicines. The company's platform specializes in reviving industrial projects where the solubility of the active substance has been problematic and current approaches have been deemed insufficient, providing drug suppliers with a platform to reformulate generic drugs and improve their bioavailability and cost-efficiency.
Contact Information
Website
www.veltiopharma.comCorporate Office
- Care of Folkesson
- Dragarbrunnsgatan 78B
- 750 03 Uppsala
- Sweden
Corporate Office
- Care of Folkesson
- Dragarbrunnsgatan 78B
- 750 03 Uppsala
- Sweden
Veltio Pharma Timeline
Veltio Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Jan-2024 | $343K | Completed | Generating Revenue | ||
| 2. Later Stage VC | 01-Jan-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 17-Mar-2022 | $385K | $385K | Completed | Generating Revenue |
Veltio Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | 20,600 | $17.54 | $17.54 | 1x | $17.54 | 18.38% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Veltio Pharma Patents
Veltio Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202507755-D0 | New compositions | Pending | 19-May-2025 | ||
| EP-3413873-A1 | New compositions | Active | 12-Feb-2016 | ||
| EP-3413873-B1 | New compositions | Active | 12-Feb-2016 | ||
| EP-3413873-C0 | New compositions | Active | 12-Feb-2016 | ||
| ES-2971977-T3 | New compositions | Active | 12-Feb-2016 | A61K9/146 |
Veltio Pharma Signals
Veltio Pharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Almi Invest | Venture Capital | Minority | ||
| Paab | Venture Capital | Minority |
Veltio Pharma FAQs
-
When was Veltio Pharma founded?
Veltio Pharma was founded in 2018.
-
Where is Veltio Pharma headquartered?
Veltio Pharma is headquartered in Uppsala, Sweden.
-
What is the size of Veltio Pharma?
Veltio Pharma has 6 total employees.
-
What industry is Veltio Pharma in?
Veltio Pharma’s primary industry is Biotechnology.
-
Is Veltio Pharma a private or public company?
Veltio Pharma is a Private company.
-
What is the current valuation of Veltio Pharma?
The current valuation of Veltio Pharma is .
-
What is Veltio Pharma’s current revenue?
The current revenue for Veltio Pharma is .
-
How much funding has Veltio Pharma raised over time?
Veltio Pharma has raised $1.02M.
-
Who are Veltio Pharma’s investors?
Almi Invest and Paab have invested in Veltio Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process